"AXON getting punished pre-market. Another dementia drug bites the dust...."
but, but, but, did they run double blinded placebo contollled trials? And didn't the CEO communicate to his shareholders on a regular basis? HOW COULD THIS BE? Dont understand they had plenty of cash and just brought in a new TOP DOG CEO!
Maybe he will quietly go away after 9 months or so.